Q2 2025 Earnings Call Transcript August 11, 2025 Kymera Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...

Phase 1 healthy volunteer data surpassing Kymera's target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in ...

Phase 1 healthy volunteer data surpassing Kymera’s target product profile, and further validating its oral, dupilumab-like profile ...

Although metformin has been the go-to medication to manage type 2 diabetes for more than 60 years, researchers still do not have a complete picture of how it works.

Lysosomal glucocerebrosidase is needed for ciliary Hedgehog signaling: A convergent pathway contributing to Parkinson’s disease ...

Propagation to the third pathway reached motion-selective middle temporal visual area (MT/V5) and subsequently the facial motion-selective superior temporal sulcus (STS) and gyrus (8). Propagation to ...

The reconstitution of the de novo nucleotide synthesis pathway from inorganic compounds for RNA transcription is essential for an autonomous artificial cell. Here, a de novo uridine triphosphate (UTP) ...

LC-MS-based metabolomics is a powerful tool in analyzing disease molecular mechanisms. Because of its high sensitivity and throughput, LC-MS-based metabolomics usually detects thousands of metabolites ...